Hormone Therapy Safe for Heart in Women Under 60 but Risky After 70
Major WHI reanalysis finds HRT cardiovascular risk hinges critically on age, with women 70+ facing nearly doubled to tripled ASCVD risk.
460 articles in this topic
Major WHI reanalysis finds HRT cardiovascular risk hinges critically on age, with women 70+ facing nearly doubled to tripled ASCVD risk.
A Bayesian network meta-analysis of 12 trials finds CAF+TAU co-supplementation outperforms each compound alone for anaerobic capacity and reaction time.
A Phase 1/2 trial evaluates whether an mRNA-based quadrivalent influenza vaccine can match or beat standard and high-dose comparators in adults.
A UCSF study maps how transfusional iron loading harms the pituitary gland and reproductive hormones in thalassemia patients.
Independent testing reveals rampant quality failures in NMN, NR, and NAD+ supplements. Know what to look for before buying.
Independent testing exposes widespread quality failures in NAD+ precursor supplements, with actionable guidance on which brands actually deliver.
Riboflavin (vitamin B2) inhibits Cryptococcus neoformans growth, dismantles biofilms, and reduces organ fungal burden in mouse models of meningitis and pneumonia.
A systematic review of 2,853 cases reveals key prolactin benchmarks that can prevent unnecessary workup and treatment.
Dr. Renato Tomioka breaks down why endometriosis goes undetected for years and how new imaging is replacing surgery for diagnosis.
Expert reviews confirm NR and NMN raise blood NAD+, but longevity proof remains elusive and product quality varies widely.
GLP-1 receptor agonists used for obesity may deliver an unexpected reproductive benefit: higher testosterone and better sperm.
A biomarker-guided treatment strategy outperforms traditional stepwise therapy, achieving hormonal control in nearly 80% of acromegaly patients.